Cargando…
Accelerating drug development for Alzheimer's disease through the use of data standards
INTRODUCTION: The exceedingly high rate of failed trials in Alzheimer's disease (AD) calls for immediate attention to improve efficiencies and learning from past, ongoing, and future trials. Accurate, highly rigorous standardized data are at the core of meaningful scientific research. Data stan...
Autores principales: | Neville, Jon, Kopko, Steve, Romero, Klaus, Corrigan, Brian, Stafford, Bob, LeRoy, Elizabeth, Broadbent, Steve, Cisneroz, Martin, Wilson, Ethan, Reiman, Eric, Vanderstichele, Hugo, Arnerić, Stephen P., Stephenson, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651436/ https://www.ncbi.nlm.nih.gov/pubmed/29067333 http://dx.doi.org/10.1016/j.trci.2017.03.006 |
Ejemplares similares
-
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019) -
World on Fire
por: Bunk, Steve
Publicado: (2004) -
Chronic Wasting Disease—Prion Disease in the Wild
por: Bunk, Steve
Publicado: (2004) -
Apps: A way to accelerate recovery?
por: Westgarth, David
Publicado: (2021) -
Facilitating the Implementation of Standardized Care Plans in Municipal Healthcare
por: Østensen, Elisabeth, et al.
Publicado: (2021)